14-102341416-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018335.6(ZNF839):c.2021C>T(p.Ala674Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000017 in 1,584,728 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018335.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF839 | NM_018335.6 | c.2021C>T | p.Ala674Val | missense_variant | 8/8 | ENST00000442396.7 | NP_060805.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF839 | ENST00000442396.7 | c.2021C>T | p.Ala674Val | missense_variant | 8/8 | 5 | NM_018335.6 | ENSP00000399863 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000396 AC: 9AN: 226990Hom.: 0 AF XY: 0.0000243 AC XY: 3AN XY: 123224
GnomAD4 exome AF: 0.0000112 AC: 16AN: 1432552Hom.: 0 Cov.: 30 AF XY: 0.00000985 AC XY: 7AN XY: 710302
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2022 | The c.2021C>T (p.A674V) alteration is located in exon 8 (coding exon 8) of the ZNF839 gene. This alteration results from a C to T substitution at nucleotide position 2021, causing the alanine (A) at amino acid position 674 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at